home / stock / knsa / knsa quote
Last: | $17.61 |
---|---|
Change Percent: | 0.84% |
Open: | $17.71 |
Close: | $17.61 |
High: | $18.11 |
Low: | $17.5 |
Volume: | 477,276 |
Last Trade Date Time: | 04/25/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$17.61 | $17.71 | $17.61 | $18.11 | $17.5 | 477,276 | 04-25-2024 |
$17.86 | $18.21 | $17.86 | $18.61 | $17.64 | 371,501 | 04-24-2024 |
$17.68 | $17.1 | $17.68 | $18.14 | $17.04 | 611,398 | 04-23-2024 |
$17.095 | $17.1 | $17.095 | $17.43 | $16.87 | 361,220 | 04-22-2024 |
$16.91 | $16.87 | $16.91 | $17.145 | $16.56 | 375,954 | 04-19-2024 |
$16.88 | $16.99 | $16.88 | $17.05 | $16.8 | 409,188 | 04-18-2024 |
$16.95 | $17.54 | $16.95 | $17.57 | $16.92 | 389,307 | 04-17-2024 |
$17.46 | $17.38 | $17.46 | $17.61 | $17.33 | 304,967 | 04-16-2024 |
$17.44 | $17.19 | $17.44 | $17.54 | $17.19 | 314,106 | 04-15-2024 |
$17.29 | $17.71 | $17.29 | $17.71 | $17.13 | 257,002 | 04-12-2024 |
$17.7 | $17.63 | $17.7 | $17.84 | $17.47 | 291,671 | 04-11-2024 |
$17.45 | $17.36 | $17.45 | $17.45 | $17.0012 | 399,417 | 04-10-2024 |
$17.73 | $17.72 | $17.73 | $18 | $17.52 | 342,701 | 04-09-2024 |
$17.68 | $17.86 | $17.68 | $17.88 | $17.62 | 312,201 | 04-08-2024 |
$17.9 | $18.01 | $17.9 | $18.18 | $17.63 | 251,134 | 04-05-2024 |
$18.06 | $18.44 | $18.06 | $18.55 | $18.02 | 368,541 | 04-04-2024 |
$18.24 | $18.61 | $18.24 | $18.61 | $17.84 | 474,592 | 04-03-2024 |
$18.73 | $19.51 | $18.73 | $19.51 | $18.45 | 425,692 | 04-02-2024 |
$19.7 | $19.64 | $19.7 | $19.73 | $19.2 | 301,528 | 04-01-2024 |
$19.73 | $20.06 | $19.73 | $20.125 | $19.47 | 359,719 | 03-29-2024 |
News, Short Squeeze, Breakout and More Instantly...
Kiniksa Pharmaceuticals Ltd. Company Name:
KNSA Stock Symbol:
NASDAQ Market:
– ARCALYST ® (rilonacept) Q1 2024 net product revenue of $78.9 million, representing 85% year-over-year growth – – ARCALYST 2024 expected net product revenue increased to $370 - $390 million – – Abiprubart Phase 2b trial in Sjög...
Kiniksa Pharmaceuticals Ltd. (KNSA) is expected to report $-0.14 for Q1 2024 Agree Realty Corporation (ADC) is expected to report $1.01 for Q1 2024 1st Colonial Bancorp Inc (FCOB) is expected to report for Q1 2024 Equity Residential of Beneficial Interest (EQR) is expected to report $...
HAMILTON, Bermuda, April 16, 2024 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) announced today that it will host a conference call and live webcast on Tuesday, April 23, 2024 at 8:30 a.m. Eastern Time to report its first quarter 2024 financial results and recent portfolio ...